HS

HighVista Strategies Portfolio holdings

AUM $408M
1-Year Est. Return 87.62%
This Quarter Est. Return
1 Year Est. Return
+87.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$408M
AUM Growth
+$136M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
175
New
Increased
Reduced
Closed

Top Buys

1 +$11.3M
2 +$6.79M
3 +$5.52M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$5.02M
5
RVMD icon
Revolution Medicines
RVMD
+$5.02M

Top Sells

1 +$6.01M
2 +$4.58M
3 +$4.37M
4
HES
Hess
HES
+$4M
5
AMED
Amedisys
AMED
+$3.86M

Sector Composition

1 Healthcare 59%
2 Technology 12.23%
3 Industrials 6.97%
4 Financials 4.42%
5 Consumer Discretionary 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFRM icon
126
Affirm
AFRM
$23B
$914K 0.22%
+12,500
NAMS icon
127
NewAmsterdam Pharma
NAMS
$4.03B
$905K 0.22%
31,831
+12,557
ETR icon
128
Entergy
ETR
$42.1B
$895K 0.22%
9,600
-5,700
KYMR icon
129
Kymera Therapeutics
KYMR
$4.75B
$890K 0.22%
+15,728
BKNG icon
130
Booking.com
BKNG
$163B
$848K 0.21%
157
-200
CTMX icon
131
CytomX Therapeutics
CTMX
$678M
$820K 0.2%
+257,148
JD icon
132
JD.com
JD
$42.4B
$818K 0.2%
23,383
+4,200
CPNG icon
133
Coupang
CPNG
$48.5B
$774K 0.19%
24,050
-18,950
TCOM icon
134
Trip.com Group
TCOM
$46.2B
$734K 0.18%
9,756
+1,300
CELC icon
135
Celcuity
CELC
$4.63B
$676K 0.17%
+13,680
BABA icon
136
Alibaba
BABA
$377B
$671K 0.16%
3,757
URGN icon
137
UroGen Pharma
URGN
$1.14B
$636K 0.16%
+31,886
NBIS
138
Nebius Group N.V.
NBIS
$24.9B
$584K 0.14%
+5,200
ALC icon
139
Alcon
ALC
$39.3B
$466K 0.11%
7,862
+1,739
BZ icon
140
Kanzhun
BZ
$10B
$442K 0.11%
18,900
-12,500
WVE icon
141
Wave Life Sciences
WVE
$1.19B
$434K 0.11%
59,261
+23,303
NOK icon
142
Nokia
NOK
$34.7B
$399K 0.1%
82,900
-600
AVTX icon
143
Avalo Therapeutics
AVTX
$308M
$353K 0.09%
+27,778
INBX icon
144
Inhibrx
INBX
$1.21B
$257K 0.06%
+7,626
TAL icon
145
TAL Education Group
TAL
$6.75B
$220K 0.05%
19,600
+1,500
BEKE icon
146
KE Holdings
BEKE
$19.4B
$217K 0.05%
+11,400
AURA icon
147
Aura Biosciences
AURA
$400M
$168K 0.04%
+27,174
MLTX icon
148
MoonLake Immunotherapeutics
MLTX
$946M
$137K 0.03%
19,059
-1,894
ADBE icon
149
Adobe
ADBE
$137B
-3,200
AMED
150
DELISTED
Amedisys
AMED
-39,250